New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Related Insights
Webinar
Incorporating the Patient Voice: How Patient Insights Drive Trial Design and Outcome Measures in Schizophrenia Research
Oct 30, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Blog
New CNS Franchise Leader brings experience from pharma and as a clinician and researcher
Nov 14, 2022
Blog
Newly released FDA data and approvals signal a more welcoming regulatory environment for neuroscience clinical trials
Oct 3, 2023
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024
Blog
Regulatory considerations in designing clinical trials for Alzheimer’s disease
Jan 24, 2024
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Increasing trial participation and population diversity in early-phase Alzheimer’s disease drug development
Jan 24, 2024
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
As more neuroscience drugs are approved, the value proposition takes center stage
Feb 14, 2024
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 29, 2024
Blog
Opportunities and strategies for accelerating patient access to treatments for Alzheimer’s disease
Feb 23, 2024
Related Insights
Webinar
Incorporating the Patient Voice: How Patient Insights Drive Trial Design and Outcome Measures in Schizophrenia Research
Oct 30, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Blog
New CNS Franchise Leader brings experience from pharma and as a clinician and researcher
Nov 14, 2022
Blog
Newly released FDA data and approvals signal a more welcoming regulatory environment for neuroscience clinical trials
Oct 3, 2023
Blog
Building a program for patient-guided clinical research for Alzheimer’s disease
Jan 24, 2024
Blog
Regulatory considerations in designing clinical trials for Alzheimer’s disease
Jan 24, 2024
Blog
Improving and accelerating clinical research in dementia by integrating the patient’s voice throughout the development journey
Jan 24, 2024
Blog
Increasing trial participation and population diversity in early-phase Alzheimer’s disease drug development
Jan 24, 2024
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
As more neuroscience drugs are approved, the value proposition takes center stage
Feb 14, 2024
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 29, 2024
Blog
Opportunities and strategies for accelerating patient access to treatments for Alzheimer’s disease
Feb 23, 2024